Versant Vantage I, L.P. is > 10% Shareholder of Repare Therapeutics Inc.. Currently has a direct ownership of 231,211 shares of RPTX, which is worth approximately $649,702. The most recent transaction as insider was on Aug 05, 2021, when has been sold 152,071 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 231K
0% 3M change
0% 12M change
Total Value Held $649,702

Versant Vantage I, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 05 2021
SELL
Other acquisition or disposition
-
152,071 Reduced 39.68%
231,211 Common Shares
Jun 01 2021
SELL
Other acquisition or disposition
-
75,000 Reduced 16.37%
383,282 Common Shares
Feb 16 2021
SELL
Other acquisition or disposition
-
50,000 Reduced 9.84%
458,282 Common Shares
Jan 29 2021
SELL
Other acquisition or disposition
-
50,000 Reduced 8.96%
508,282 Common Shares
Jan 14 2021
SELL
Other acquisition or disposition
-
50,000 Reduced 8.22%
558,282 Common Shares
VVI

Versant Vantage I, L.P.

> 10% Shareholder
San Francisco, CA

Track Institutional and Insider Activities on RPTX

Follow Repare Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPTX shares.

Notify only if

Insider Trading

Get notified when an Repare Therapeutics Inc. insider buys or sells RPTX shares.

Notify only if

News

Receive news related to Repare Therapeutics Inc.

Track Activities on RPTX